StonvexLoading…
StonvexStonvexStonvexCore line items from OLLI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $2.65B | $1.87B | $1.26B | $576.77M |
Operating Income | $297.67M | $188.57M | $133.16M | $56.19M |
Net Income | $240.60M | $155.04M | $108.87M | $47.56M |
EPS (Diluted) | $3.89 | $2.51 | $1.76 | $0.77 |
Total Assets | $2.95B | $2.86B | $2.80B | $2.71B |
Total Liabilities | $1.07B | $1.02B | $1.02B | $977.17M |
Cash & Equivalents | $259.68M | $144.70M | $231.16M | $199.02M |
Free Cash Flow OCF − CapEx | $194.66M | $30.28M | $56.26M | $1.96M |
Shares Outstanding | 61.77M | 61.81M | 61.81M | 61.82M |